ArticleFrontiers in medicine2026
Mortality prediction in the elderly patients with coronary artery disease and atrial fibrillation: a retrospective machine learning approach.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Elderly patients with coexisting coronary artery disease (CAD) and atrial fibrillation (AF) are at significantly increased risk of mortality. Accurate risk stratification is crucial for improving clinical management, yet a dedicated predictive tool for this specific population is lacking. The widely used CHA Methods: A cohort of elderly inpatients (≥65 years) diagnosed with CAD and AF were retrospectively enrolled from the Department of Cardiology at the Chinese PLA General Hospital between January 2010 and December 2017. Baseline clinical data during hospitalization were collected, and all patients were followed up for all-cause mortality. Patients were randomly divided into a training set (70%) and a validation set (30%). Variable selection was performed using LASSO-Cox regression. Predictive models were established through a Cox proportional hazards model (via LASSO-Cox) to predict all-cause mortality risk. To assess model robustness and address potential overfitting, we performed 10-fold cross-validation and bootstrap resampling (500 replicates) with optimism-corrected C-statistics. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC), calibration curves, and decision curve analysis (DCA), and compared against the CHA Results: A total of 1678 elderly patients with CAD and AF were randomly divided into a training set ( Conclusion: The LASSO-Cox machine learning model demonstrates superior predictive performance for all cause mortality relative to the traditional CHA
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.